🇺🇸 FDA
Patent

US 11118170

Engineered clostridium botulinum toxin adapted to deliver molecules into selected cells

granted A61KA61K38/45A61K47/6415

Quick answer

US patent 11118170 (Engineered clostridium botulinum toxin adapted to deliver molecules into selected cells) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/45, A61K47/6415, A61K49/0056, A61P